← Latest Filings
G
Gallagher Kathleen P.
Open-market buys
0
$0 total
Open-market sells
0
$0 total
Tracking since
N/A
Activity timeline
No individual transactions on file yet — aggregate totals above are current.
Holdings as last reported
205,000 Stock Option (Right to Buy) in RNA
Held directly · as of 2026-04-20
119,729 Common Stock in RNA
Held directly · as of 2026-09-18
Companies touched
Avidity Biosciences, Inc
CIK 0001599901
Atrium Therapeutics, Inc.
CIK 0002093101
